About

Calibrate focuses on sustainable weight loss by improving metabolic health instead of traditional dieting. Their program combines habit changes with medication that targets underlying biological factors. This approach has reportedly led to a 15% sustained weight loss in real-world settings. Calibrate operates on a subscription model, often supported by employers for employee wellness, but individuals can also join. The program utilizes GLP-1 medications to enhance metabolic function and reduce health risks. Unlike many competitors, Calibrate's method is non-restrictive and easy to maintain, backed by a money-back guarantee for users who do not see results. The goal is to provide an effective, science-based solution for weight loss and overall wellness.

Simplify's Take

What believers are saying

• The appointment of Rob MacNaughton as CEO, with his extensive experience in healthcare ventures, positions Calibrate for strategic growth and innovation.
• Recent funding rounds, including a $100M investment, indicate strong financial backing and potential for expansion.
• Calibrate's partnerships with industry leaders like OptumRx enhance its credibility and market reach.

What critics are saying

• Patient complaints and the need for refunds could damage Calibrate's reputation and customer trust.
• The company's reliance on GLP-1 medications, which have faced accessibility issues, could hinder program effectiveness and customer satisfaction.

What makes Calibrate unique

• Calibrate's focus on metabolic health and the use of GLP-1s for sustainable weight loss sets it apart from traditional dieting programs.
• The company's subscription-based model, often covered by employers, provides a unique revenue stream and positions it as a corporate wellness solution.
• Calibrate's money-back guarantee demonstrates a high level of confidence in their program's effectiveness, which is rare in the weight loss industry.

Help us improve and share your feedback! Did you find this helpful?

YesNo